Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Long-Term Investments (2019 - 2022)

Silo Pharma's Long-Term Investments history spans 4 years, with the latest figure at $77939.0 for Q3 2022.

  • For Q3 2022, Long-Term Investments changed N/A year-over-year to $77939.0; the TTM value through Sep 2022 reached $77939.0, changed N/A, while the annual FY2021 figure was $419995.0, 209897.5% up from the prior year.
  • Long-Term Investments for Q3 2022 was $77939.0 at Silo Pharma, down from $419995.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $600000.0 in Q2 2021 and bottomed at $200.0 in Q4 2020.
  • The 4-year median for Long-Term Investments is $11080.0 (2019), against an average of $145053.0.
  • The largest annual shift saw Long-Term Investments tumbled 97.87% in 2020 before it surged 209897.5% in 2021.
  • A 4-year view of Long-Term Investments shows it stood at $9394.0 in 2019, then crashed by 97.87% to $200.0 in 2020, then soared by 209897.5% to $419995.0 in 2021, then plummeted by 81.44% to $77939.0 in 2022.
  • Per Business Quant, the three most recent readings for SILO's Long-Term Investments are $77939.0 (Q3 2022), $419995.0 (Q4 2021), and $600000.0 (Q2 2021).